Zoomedia Blog
Blog Posts for Tag: social media
On July 29, 2010, the FDA issued a warning letter to Novartis stating that content shared through Facebook and ShareThis functionality "... is misleading because it makes representations about the efficacy of Tasigna but fails to communicate any risk information associated with the use of this drug. In addition, the shared content inadequately communicates Tasigna’s FDA-approved indication and implies superiority over other products."
Tags: FDA, regulatory, warning letter, social media, Facebook
One of the most successful social media campaigns to date has just made its run – and Old Spice is suddenly hip again. So, what has made this campaign so successful and what can biotech and pharma learn from it? Here are a few reasons why we think it worked so well...
Tags: YouTube, social media
Zoomedia is proud to help support the Parkinson’s Disease Foundation (PDF) during Parkinson’s Awareness month. Throughout April, we encourage you to download their comprehensive 36-page outreach toolkit to learn about ways you can spread the word, too! The kit contains everything you need to launch a media campaign by yourself or with your company’s support.
Tags: parkinsons, nonprofit, social media, campaign
Despite the lack of any formal guidance from the FDA on how drugs and devices can be discussed and/or promoted through social media channels like Twitter, Facebook and the like, dozens of firms are exploring what fits them best. There are plenty of examples out there but I took a look at three approaches that seem to be getting attention based on their volume of views and fans; J&J, Bayer Diabetes, and GSK.
Tags: social media, cause awareness, Facebook
Day One included 10 minute presentations and statements by over a dozen agencies, 3 pharmaceutical companies (J&J, Sanofi Aventis, and Eli Lilly & Company) and the Internet heavy hitters including Wayne Gatinella, WebMD, David Zinman from Yahoo, Mary Anne Belliveau and Amy Cowan from Google and a nicely done data dump on Internet usage by physicians and online health information seekers from Mark Bard at Manhattan Research.
There was also a heavy helping of PhRMA and IAB waffling that seemed to say “we recognize the need for ideas, we just don’t have any right now…” but I admit to being a little bitter due to the enormous line for coffee and once I got some the “rules” not allowing any in the meeting room…
Tags: FDA, DDMAC, pharmaceuticals, DTC, social media, marketing
